Global Tagrisso (Osimertinib) Market Research Report 2025(Status and Outlook)
Tagrisso (osimertinib) is a third-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor specifically designed to target both EGFR-sensitizing mutations (such as exon 19 deletions and exon 21 L858R mutations) and the EGFR T790M resistance mutation, which often arises after treatment with first-generation EGFR inhibitors in patients with non-small cell lung cancer (NSCLC); it is orally administered and functions by covalently binding to specific cysteine residues in the ATP-binding site of mutant EGFR, thereby inhibiting downstream signaling pathways and inducing apoptosis in cancer cells while exhibiting reduced activity against wild-type EGFR, which contributes to its improved safety profile compared to earlier-generation inhibitors.The global market for Tagrisso (osimertinib) is robust and continues to expand, driven by its established role as a first-line treatment for EGFR-mutant NSCLC and its efficacy in the adjuvant setting following tumor resection. Key factors fueling market growth include the rising incidence of NSCLC, particularly in Asia where EGFR mutation rates are high, increased diagnostic capabilities for biomarker testing, and strong clinical data supporting its survival benefits and manageable toxicity profile. AstraZeneca, as the sole manufacturer, maintains a dominant position, with sales exceeding $5 billion annually, supported by approvals in major markets such as the U.S., EU, Japan, and China. Competition is emerging from other EGFR-targeted therapies like amivantamab and newer TKIs in development, but Tagrisso?s first-mover advantage, extensive real-world evidence, and expanding indications?such as its use in combination regimens?cement its leadership. Market challenges include pricing pressures, payer reimbursement policies, and the eventual entry of biosimilars post-patent expiry, though patent protection in key regions remains until the early 2030s. The ongoing exploration of Tagrisso in earlier disease stages and novel combinations positions it for sustained growth, contingent on continued innovation and adaptive commercial strategies.
The global Tagrisso (Osimertinib) market size was estimated at USD 5897.63 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Tagrisso (Osimertinib) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Tagrisso (Osimertinib) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Tagrisso (Osimertinib) market.
Global Tagrisso (Osimertinib) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
AstraZenecaIncepta Pharmaceuticals Ltd
Lonza AG
Everest Pharmaceuticals
Beacon Pharmaceuticals Limited
Drug International Limited
Market Segmentation (by Type)
40 mg
80 mg
Market Segmentation (by Application)
Locally Advanced NSCLC
Metastatic NSCLC
Other
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Tagrisso (Osimertinib) Market
Overview of the regional outlook of the Tagrisso (Osimertinib) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tagrisso (Osimertinib) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Tagrisso (Osimertinib), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Tagrisso (Osimertinib) market size was estimated at USD 5897.63 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Tagrisso (Osimertinib) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Tagrisso (Osimertinib) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Tagrisso (Osimertinib) market.
Global Tagrisso (Osimertinib) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
AstraZenecaIncepta Pharmaceuticals Ltd
Lonza AG
Everest Pharmaceuticals
Beacon Pharmaceuticals Limited
Drug International Limited
Market Segmentation (by Type)
40 mg
80 mg
Market Segmentation (by Application)
Locally Advanced NSCLC
Metastatic NSCLC
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Tagrisso (Osimertinib) Market
Overview of the regional outlook of the Tagrisso (Osimertinib) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tagrisso (Osimertinib) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Tagrisso (Osimertinib), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Tagrisso (Osimertinib)
1.2 Key Market Segments
1.2.1 Tagrisso (Osimertinib) Segment by Type
1.2.2 Tagrisso (Osimertinib) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TAGRISSO (OSIMERTINIB) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tagrisso (Osimertinib) Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Tagrisso (Osimertinib) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TAGRISSO (OSIMERTINIB) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Tagrisso (Osimertinib) Product Life Cycle
3.3 Global Tagrisso (Osimertinib) Sales by Manufacturers (2020-2025)
3.4 Global Tagrisso (Osimertinib) Revenue Market Share by Manufacturers (2020-2025)
3.5 Tagrisso (Osimertinib) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Tagrisso (Osimertinib) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Tagrisso (Osimertinib) Market Competitive Situation and Trends
3.8.1 Tagrisso (Osimertinib) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Tagrisso (Osimertinib) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TAGRISSO (OSIMERTINIB) INDUSTRY CHAIN ANALYSIS
4.1 Tagrisso (Osimertinib) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TAGRISSO (OSIMERTINIB) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Tagrisso (Osimertinib) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Tagrisso (Osimertinib) Market
5.7 ESG Ratings of Leading Companies
6 TAGRISSO (OSIMERTINIB) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tagrisso (Osimertinib) Sales Market Share by Type (2020-2025)
6.3 Global Tagrisso (Osimertinib) Market Size Market Share by Type (2020-2025)
6.4 Global Tagrisso (Osimertinib) Price by Type (2020-2025)
7 TAGRISSO (OSIMERTINIB) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tagrisso (Osimertinib) Market Sales by Application (2020-2025)
7.3 Global Tagrisso (Osimertinib) Market Size (M USD) by Application (2020-2025)
7.4 Global Tagrisso (Osimertinib) Sales Growth Rate by Application (2020-2025)
8 TAGRISSO (OSIMERTINIB) MARKET SALES BY REGION
8.1 Global Tagrisso (Osimertinib) Sales by Region
8.1.1 Global Tagrisso (Osimertinib) Sales by Region
8.1.2 Global Tagrisso (Osimertinib) Sales Market Share by Region
8.2 Global Tagrisso (Osimertinib) Market Size by Region
8.2.1 Global Tagrisso (Osimertinib) Market Size by Region
8.2.2 Global Tagrisso (Osimertinib) Market Size Market Share by Region
8.3 North America
8.3.1 North America Tagrisso (Osimertinib) Sales by Country
8.3.2 North America Tagrisso (Osimertinib) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Tagrisso (Osimertinib) Sales by Country
8.4.2 Europe Tagrisso (Osimertinib) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Tagrisso (Osimertinib) Sales by Region
8.5.2 Asia Pacific Tagrisso (Osimertinib) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Tagrisso (Osimertinib) Sales by Country
8.6.2 South America Tagrisso (Osimertinib) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Tagrisso (Osimertinib) Sales by Region
8.7.2 Middle East and Africa Tagrisso (Osimertinib) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TAGRISSO (OSIMERTINIB) MARKET PRODUCTION BY REGION
9.1 Global Production of Tagrisso (Osimertinib) by Region(2020-2025)
9.2 Global Tagrisso (Osimertinib) Revenue Market Share by Region (2020-2025)
9.3 Global Tagrisso (Osimertinib) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Tagrisso (Osimertinib) Production
9.4.1 North America Tagrisso (Osimertinib) Production Growth Rate (2020-2025)
9.4.2 North America Tagrisso (Osimertinib) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Tagrisso (Osimertinib) Production
9.5.1 Europe Tagrisso (Osimertinib) Production Growth Rate (2020-2025)
9.5.2 Europe Tagrisso (Osimertinib) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Tagrisso (Osimertinib) Production (2020-2025)
9.6.1 Japan Tagrisso (Osimertinib) Production Growth Rate (2020-2025)
9.6.2 Japan Tagrisso (Osimertinib) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Tagrisso (Osimertinib) Production (2020-2025)
9.7.1 China Tagrisso (Osimertinib) Production Growth Rate (2020-2025)
9.7.2 China Tagrisso (Osimertinib) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 AstraZenecaIncepta Pharmaceuticals Ltd
10.1.1 AstraZenecaIncepta Pharmaceuticals Ltd Basic Information
10.1.2 AstraZenecaIncepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product Overview
10.1.3 AstraZenecaIncepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product Market Performance
10.1.4 AstraZenecaIncepta Pharmaceuticals Ltd Business Overview
10.1.5 AstraZenecaIncepta Pharmaceuticals Ltd SWOT Analysis
10.1.6 AstraZenecaIncepta Pharmaceuticals Ltd Recent Developments
10.2 Lonza AG
10.2.1 Lonza AG Basic Information
10.2.2 Lonza AG Tagrisso (Osimertinib) Product Overview
10.2.3 Lonza AG Tagrisso (Osimertinib) Product Market Performance
10.2.4 Lonza AG Business Overview
10.2.5 Lonza AG SWOT Analysis
10.2.6 Lonza AG Recent Developments
10.3 Everest Pharmaceuticals
10.3.1 Everest Pharmaceuticals Basic Information
10.3.2 Everest Pharmaceuticals Tagrisso (Osimertinib) Product Overview
10.3.3 Everest Pharmaceuticals Tagrisso (Osimertinib) Product Market Performance
10.3.4 Everest Pharmaceuticals Business Overview
10.3.5 Everest Pharmaceuticals SWOT Analysis
10.3.6 Everest Pharmaceuticals Recent Developments
10.4 Beacon Pharmaceuticals Limited
10.4.1 Beacon Pharmaceuticals Limited Basic Information
10.4.2 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product Overview
10.4.3 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product Market Performance
10.4.4 Beacon Pharmaceuticals Limited Business Overview
10.4.5 Beacon Pharmaceuticals Limited Recent Developments
10.5 Drug International Limited
10.5.1 Drug International Limited Basic Information
10.5.2 Drug International Limited Tagrisso (Osimertinib) Product Overview
10.5.3 Drug International Limited Tagrisso (Osimertinib) Product Market Performance
10.5.4 Drug International Limited Business Overview
10.5.5 Drug International Limited Recent Developments
11 TAGRISSO (OSIMERTINIB) MARKET FORECAST BY REGION
11.1 Global Tagrisso (Osimertinib) Market Size Forecast
11.2 Global Tagrisso (Osimertinib) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Tagrisso (Osimertinib) Market Size Forecast by Country
11.2.3 Asia Pacific Tagrisso (Osimertinib) Market Size Forecast by Region
11.2.4 South America Tagrisso (Osimertinib) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Tagrisso (Osimertinib) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Tagrisso (Osimertinib) Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Tagrisso (Osimertinib) by Type (2026-2033)
12.1.2 Global Tagrisso (Osimertinib) Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Tagrisso (Osimertinib) by Type (2026-2033)
12.2 Global Tagrisso (Osimertinib) Market Forecast by Application (2026-2033)
12.2.1 Global Tagrisso (Osimertinib) Sales (K MT) Forecast by Application
12.2.2 Global Tagrisso (Osimertinib) Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Tagrisso (Osimertinib)
1.2 Key Market Segments
1.2.1 Tagrisso (Osimertinib) Segment by Type
1.2.2 Tagrisso (Osimertinib) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TAGRISSO (OSIMERTINIB) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tagrisso (Osimertinib) Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Tagrisso (Osimertinib) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TAGRISSO (OSIMERTINIB) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Tagrisso (Osimertinib) Product Life Cycle
3.3 Global Tagrisso (Osimertinib) Sales by Manufacturers (2020-2025)
3.4 Global Tagrisso (Osimertinib) Revenue Market Share by Manufacturers (2020-2025)
3.5 Tagrisso (Osimertinib) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Tagrisso (Osimertinib) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Tagrisso (Osimertinib) Market Competitive Situation and Trends
3.8.1 Tagrisso (Osimertinib) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Tagrisso (Osimertinib) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TAGRISSO (OSIMERTINIB) INDUSTRY CHAIN ANALYSIS
4.1 Tagrisso (Osimertinib) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TAGRISSO (OSIMERTINIB) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Tagrisso (Osimertinib) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Tagrisso (Osimertinib) Market
5.7 ESG Ratings of Leading Companies
6 TAGRISSO (OSIMERTINIB) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tagrisso (Osimertinib) Sales Market Share by Type (2020-2025)
6.3 Global Tagrisso (Osimertinib) Market Size Market Share by Type (2020-2025)
6.4 Global Tagrisso (Osimertinib) Price by Type (2020-2025)
7 TAGRISSO (OSIMERTINIB) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tagrisso (Osimertinib) Market Sales by Application (2020-2025)
7.3 Global Tagrisso (Osimertinib) Market Size (M USD) by Application (2020-2025)
7.4 Global Tagrisso (Osimertinib) Sales Growth Rate by Application (2020-2025)
8 TAGRISSO (OSIMERTINIB) MARKET SALES BY REGION
8.1 Global Tagrisso (Osimertinib) Sales by Region
8.1.1 Global Tagrisso (Osimertinib) Sales by Region
8.1.2 Global Tagrisso (Osimertinib) Sales Market Share by Region
8.2 Global Tagrisso (Osimertinib) Market Size by Region
8.2.1 Global Tagrisso (Osimertinib) Market Size by Region
8.2.2 Global Tagrisso (Osimertinib) Market Size Market Share by Region
8.3 North America
8.3.1 North America Tagrisso (Osimertinib) Sales by Country
8.3.2 North America Tagrisso (Osimertinib) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Tagrisso (Osimertinib) Sales by Country
8.4.2 Europe Tagrisso (Osimertinib) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Tagrisso (Osimertinib) Sales by Region
8.5.2 Asia Pacific Tagrisso (Osimertinib) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Tagrisso (Osimertinib) Sales by Country
8.6.2 South America Tagrisso (Osimertinib) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Tagrisso (Osimertinib) Sales by Region
8.7.2 Middle East and Africa Tagrisso (Osimertinib) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TAGRISSO (OSIMERTINIB) MARKET PRODUCTION BY REGION
9.1 Global Production of Tagrisso (Osimertinib) by Region(2020-2025)
9.2 Global Tagrisso (Osimertinib) Revenue Market Share by Region (2020-2025)
9.3 Global Tagrisso (Osimertinib) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Tagrisso (Osimertinib) Production
9.4.1 North America Tagrisso (Osimertinib) Production Growth Rate (2020-2025)
9.4.2 North America Tagrisso (Osimertinib) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Tagrisso (Osimertinib) Production
9.5.1 Europe Tagrisso (Osimertinib) Production Growth Rate (2020-2025)
9.5.2 Europe Tagrisso (Osimertinib) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Tagrisso (Osimertinib) Production (2020-2025)
9.6.1 Japan Tagrisso (Osimertinib) Production Growth Rate (2020-2025)
9.6.2 Japan Tagrisso (Osimertinib) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Tagrisso (Osimertinib) Production (2020-2025)
9.7.1 China Tagrisso (Osimertinib) Production Growth Rate (2020-2025)
9.7.2 China Tagrisso (Osimertinib) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 AstraZenecaIncepta Pharmaceuticals Ltd
10.1.1 AstraZenecaIncepta Pharmaceuticals Ltd Basic Information
10.1.2 AstraZenecaIncepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product Overview
10.1.3 AstraZenecaIncepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product Market Performance
10.1.4 AstraZenecaIncepta Pharmaceuticals Ltd Business Overview
10.1.5 AstraZenecaIncepta Pharmaceuticals Ltd SWOT Analysis
10.1.6 AstraZenecaIncepta Pharmaceuticals Ltd Recent Developments
10.2 Lonza AG
10.2.1 Lonza AG Basic Information
10.2.2 Lonza AG Tagrisso (Osimertinib) Product Overview
10.2.3 Lonza AG Tagrisso (Osimertinib) Product Market Performance
10.2.4 Lonza AG Business Overview
10.2.5 Lonza AG SWOT Analysis
10.2.6 Lonza AG Recent Developments
10.3 Everest Pharmaceuticals
10.3.1 Everest Pharmaceuticals Basic Information
10.3.2 Everest Pharmaceuticals Tagrisso (Osimertinib) Product Overview
10.3.3 Everest Pharmaceuticals Tagrisso (Osimertinib) Product Market Performance
10.3.4 Everest Pharmaceuticals Business Overview
10.3.5 Everest Pharmaceuticals SWOT Analysis
10.3.6 Everest Pharmaceuticals Recent Developments
10.4 Beacon Pharmaceuticals Limited
10.4.1 Beacon Pharmaceuticals Limited Basic Information
10.4.2 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product Overview
10.4.3 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product Market Performance
10.4.4 Beacon Pharmaceuticals Limited Business Overview
10.4.5 Beacon Pharmaceuticals Limited Recent Developments
10.5 Drug International Limited
10.5.1 Drug International Limited Basic Information
10.5.2 Drug International Limited Tagrisso (Osimertinib) Product Overview
10.5.3 Drug International Limited Tagrisso (Osimertinib) Product Market Performance
10.5.4 Drug International Limited Business Overview
10.5.5 Drug International Limited Recent Developments
11 TAGRISSO (OSIMERTINIB) MARKET FORECAST BY REGION
11.1 Global Tagrisso (Osimertinib) Market Size Forecast
11.2 Global Tagrisso (Osimertinib) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Tagrisso (Osimertinib) Market Size Forecast by Country
11.2.3 Asia Pacific Tagrisso (Osimertinib) Market Size Forecast by Region
11.2.4 South America Tagrisso (Osimertinib) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Tagrisso (Osimertinib) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Tagrisso (Osimertinib) Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Tagrisso (Osimertinib) by Type (2026-2033)
12.1.2 Global Tagrisso (Osimertinib) Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Tagrisso (Osimertinib) by Type (2026-2033)
12.2 Global Tagrisso (Osimertinib) Market Forecast by Application (2026-2033)
12.2.1 Global Tagrisso (Osimertinib) Sales (K MT) Forecast by Application
12.2.2 Global Tagrisso (Osimertinib) Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tagrisso (Osimertinib) Market Size Comparison by Region (M USD)
Table 5. Global Tagrisso (Osimertinib) Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Tagrisso (Osimertinib) Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Tagrisso (Osimertinib) Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Tagrisso (Osimertinib) Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tagrisso (Osimertinib) as of 2024)
Table 10. Global Market Tagrisso (Osimertinib) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Tagrisso (Osimertinib) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Tagrisso (Osimertinib) Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Tagrisso (Osimertinib) Sales by Type (K MT)
Table 26. Global Tagrisso (Osimertinib) Market Size by Type (M USD)
Table 27. Global Tagrisso (Osimertinib) Sales (K MT) by Type (2020-2025)
Table 28. Global Tagrisso (Osimertinib) Sales Market Share by Type (2020-2025)
Table 29. Global Tagrisso (Osimertinib) Market Size (M USD) by Type (2020-2025)
Table 30. Global Tagrisso (Osimertinib) Market Size Share by Type (2020-2025)
Table 31. Global Tagrisso (Osimertinib) Price (USD/KG) by Type (2020-2025)
Table 32. Global Tagrisso (Osimertinib) Sales (K MT) by Application
Table 33. Global Tagrisso (Osimertinib) Market Size by Application
Table 34. Global Tagrisso (Osimertinib) Sales by Application (2020-2025) & (K MT)
Table 35. Global Tagrisso (Osimertinib) Sales Market Share by Application (2020-2025)
Table 36. Global Tagrisso (Osimertinib) Market Size by Application (2020-2025) & (M USD)
Table 37. Global Tagrisso (Osimertinib) Market Share by Application (2020-2025)
Table 38. Global Tagrisso (Osimertinib) Sales Growth Rate by Application (2020-2025)
Table 39. Global Tagrisso (Osimertinib) Sales by Region (2020-2025) & (K MT)
Table 40. Global Tagrisso (Osimertinib) Sales Market Share by Region (2020-2025)
Table 41. Global Tagrisso (Osimertinib) Market Size by Region (2020-2025) & (M USD)
Table 42. Global Tagrisso (Osimertinib) Market Size Market Share by Region (2020-2025)
Table 43. North America Tagrisso (Osimertinib) Sales by Country (2020-2025) & (K MT)
Table 44. North America Tagrisso (Osimertinib) Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Tagrisso (Osimertinib) Sales by Country (2020-2025) & (K MT)
Table 46. Europe Tagrisso (Osimertinib) Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Tagrisso (Osimertinib) Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Tagrisso (Osimertinib) Market Size by Region (2020-2025) & (M USD)
Table 49. South America Tagrisso (Osimertinib) Sales by Country (2020-2025) & (K MT)
Table 50. South America Tagrisso (Osimertinib) Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Tagrisso (Osimertinib) Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Tagrisso (Osimertinib) Market Size by Region (2020-2025) & (M USD)
Table 53. Global Tagrisso (Osimertinib) Production (K MT) by Region(2020-2025)
Table 54. Global Tagrisso (Osimertinib) Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Tagrisso (Osimertinib) Revenue Market Share by Region (2020-2025)
Table 56. Global Tagrisso (Osimertinib) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Tagrisso (Osimertinib) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Tagrisso (Osimertinib) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Tagrisso (Osimertinib) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Tagrisso (Osimertinib) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. AstraZenecaIncepta Pharmaceuticals Ltd Basic Information
Table 62. AstraZenecaIncepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product Overview
Table 63. AstraZenecaIncepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. AstraZenecaIncepta Pharmaceuticals Ltd Business Overview
Table 65. AstraZenecaIncepta Pharmaceuticals Ltd SWOT Analysis
Table 66. AstraZenecaIncepta Pharmaceuticals Ltd Recent Developments
Table 67. Lonza AG Basic Information
Table 68. Lonza AG Tagrisso (Osimertinib) Product Overview
Table 69. Lonza AG Tagrisso (Osimertinib) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Lonza AG Business Overview
Table 71. Lonza AG SWOT Analysis
Table 72. Lonza AG Recent Developments
Table 73. Everest Pharmaceuticals Basic Information
Table 74. Everest Pharmaceuticals Tagrisso (Osimertinib) Product Overview
Table 75. Everest Pharmaceuticals Tagrisso (Osimertinib) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Everest Pharmaceuticals Business Overview
Table 77. Everest Pharmaceuticals SWOT Analysis
Table 78. Everest Pharmaceuticals Recent Developments
Table 79. Beacon Pharmaceuticals Limited Basic Information
Table 80. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product Overview
Table 81. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Beacon Pharmaceuticals Limited Business Overview
Table 83. Beacon Pharmaceuticals Limited Recent Developments
Table 84. Drug International Limited Basic Information
Table 85. Drug International Limited Tagrisso (Osimertinib) Product Overview
Table 86. Drug International Limited Tagrisso (Osimertinib) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Drug International Limited Business Overview
Table 88. Drug International Limited Recent Developments
Table 89. Global Tagrisso (Osimertinib) Sales Forecast by Region (2026-2033) & (K MT)
Table 90. Global Tagrisso (Osimertinib) Market Size Forecast by Region (2026-2033) & (M USD)
Table 91. North America Tagrisso (Osimertinib) Sales Forecast by Country (2026-2033) & (K MT)
Table 92. North America Tagrisso (Osimertinib) Market Size Forecast by Country (2026-2033) & (M USD)
Table 93. Europe Tagrisso (Osimertinib) Sales Forecast by Country (2026-2033) & (K MT)
Table 94. Europe Tagrisso (Osimertinib) Market Size Forecast by Country (2026-2033) & (M USD)
Table 95. Asia Pacific Tagrisso (Osimertinib) Sales Forecast by Region (2026-2033) & (K MT)
Table 96. Asia Pacific Tagrisso (Osimertinib) Market Size Forecast by Region (2026-2033) & (M USD)
Table 97. South America Tagrisso (Osimertinib) Sales Forecast by Country (2026-2033) & (K MT)
Table 98. South America Tagrisso (Osimertinib) Market Size Forecast by Country (2026-2033) & (M USD)
Table 99. Middle East and Africa Tagrisso (Osimertinib) Sales Forecast by Country (2026-2033) & (Units)
Table 100. Middle East and Africa Tagrisso (Osimertinib) Market Size Forecast by Country (2026-2033) & (M USD)
Table 101. Global Tagrisso (Osimertinib) Sales Forecast by Type (2026-2033) & (K MT)
Table 102. Global Tagrisso (Osimertinib) Market Size Forecast by Type (2026-2033) & (M USD)
Table 103. Global Tagrisso (Osimertinib) Price Forecast by Type (2026-2033) & (USD/KG)
Table 104. Global Tagrisso (Osimertinib) Sales (K MT) Forecast by Application (2026-2033)
Table 105. Global Tagrisso (Osimertinib) Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tagrisso (Osimertinib) Market Size Comparison by Region (M USD)
Table 5. Global Tagrisso (Osimertinib) Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Tagrisso (Osimertinib) Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Tagrisso (Osimertinib) Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Tagrisso (Osimertinib) Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tagrisso (Osimertinib) as of 2024)
Table 10. Global Market Tagrisso (Osimertinib) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Tagrisso (Osimertinib) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Tagrisso (Osimertinib) Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Tagrisso (Osimertinib) Sales by Type (K MT)
Table 26. Global Tagrisso (Osimertinib) Market Size by Type (M USD)
Table 27. Global Tagrisso (Osimertinib) Sales (K MT) by Type (2020-2025)
Table 28. Global Tagrisso (Osimertinib) Sales Market Share by Type (2020-2025)
Table 29. Global Tagrisso (Osimertinib) Market Size (M USD) by Type (2020-2025)
Table 30. Global Tagrisso (Osimertinib) Market Size Share by Type (2020-2025)
Table 31. Global Tagrisso (Osimertinib) Price (USD/KG) by Type (2020-2025)
Table 32. Global Tagrisso (Osimertinib) Sales (K MT) by Application
Table 33. Global Tagrisso (Osimertinib) Market Size by Application
Table 34. Global Tagrisso (Osimertinib) Sales by Application (2020-2025) & (K MT)
Table 35. Global Tagrisso (Osimertinib) Sales Market Share by Application (2020-2025)
Table 36. Global Tagrisso (Osimertinib) Market Size by Application (2020-2025) & (M USD)
Table 37. Global Tagrisso (Osimertinib) Market Share by Application (2020-2025)
Table 38. Global Tagrisso (Osimertinib) Sales Growth Rate by Application (2020-2025)
Table 39. Global Tagrisso (Osimertinib) Sales by Region (2020-2025) & (K MT)
Table 40. Global Tagrisso (Osimertinib) Sales Market Share by Region (2020-2025)
Table 41. Global Tagrisso (Osimertinib) Market Size by Region (2020-2025) & (M USD)
Table 42. Global Tagrisso (Osimertinib) Market Size Market Share by Region (2020-2025)
Table 43. North America Tagrisso (Osimertinib) Sales by Country (2020-2025) & (K MT)
Table 44. North America Tagrisso (Osimertinib) Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Tagrisso (Osimertinib) Sales by Country (2020-2025) & (K MT)
Table 46. Europe Tagrisso (Osimertinib) Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Tagrisso (Osimertinib) Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Tagrisso (Osimertinib) Market Size by Region (2020-2025) & (M USD)
Table 49. South America Tagrisso (Osimertinib) Sales by Country (2020-2025) & (K MT)
Table 50. South America Tagrisso (Osimertinib) Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Tagrisso (Osimertinib) Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Tagrisso (Osimertinib) Market Size by Region (2020-2025) & (M USD)
Table 53. Global Tagrisso (Osimertinib) Production (K MT) by Region(2020-2025)
Table 54. Global Tagrisso (Osimertinib) Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Tagrisso (Osimertinib) Revenue Market Share by Region (2020-2025)
Table 56. Global Tagrisso (Osimertinib) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Tagrisso (Osimertinib) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Tagrisso (Osimertinib) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Tagrisso (Osimertinib) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Tagrisso (Osimertinib) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. AstraZenecaIncepta Pharmaceuticals Ltd Basic Information
Table 62. AstraZenecaIncepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product Overview
Table 63. AstraZenecaIncepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. AstraZenecaIncepta Pharmaceuticals Ltd Business Overview
Table 65. AstraZenecaIncepta Pharmaceuticals Ltd SWOT Analysis
Table 66. AstraZenecaIncepta Pharmaceuticals Ltd Recent Developments
Table 67. Lonza AG Basic Information
Table 68. Lonza AG Tagrisso (Osimertinib) Product Overview
Table 69. Lonza AG Tagrisso (Osimertinib) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Lonza AG Business Overview
Table 71. Lonza AG SWOT Analysis
Table 72. Lonza AG Recent Developments
Table 73. Everest Pharmaceuticals Basic Information
Table 74. Everest Pharmaceuticals Tagrisso (Osimertinib) Product Overview
Table 75. Everest Pharmaceuticals Tagrisso (Osimertinib) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Everest Pharmaceuticals Business Overview
Table 77. Everest Pharmaceuticals SWOT Analysis
Table 78. Everest Pharmaceuticals Recent Developments
Table 79. Beacon Pharmaceuticals Limited Basic Information
Table 80. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product Overview
Table 81. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Beacon Pharmaceuticals Limited Business Overview
Table 83. Beacon Pharmaceuticals Limited Recent Developments
Table 84. Drug International Limited Basic Information
Table 85. Drug International Limited Tagrisso (Osimertinib) Product Overview
Table 86. Drug International Limited Tagrisso (Osimertinib) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Drug International Limited Business Overview
Table 88. Drug International Limited Recent Developments
Table 89. Global Tagrisso (Osimertinib) Sales Forecast by Region (2026-2033) & (K MT)
Table 90. Global Tagrisso (Osimertinib) Market Size Forecast by Region (2026-2033) & (M USD)
Table 91. North America Tagrisso (Osimertinib) Sales Forecast by Country (2026-2033) & (K MT)
Table 92. North America Tagrisso (Osimertinib) Market Size Forecast by Country (2026-2033) & (M USD)
Table 93. Europe Tagrisso (Osimertinib) Sales Forecast by Country (2026-2033) & (K MT)
Table 94. Europe Tagrisso (Osimertinib) Market Size Forecast by Country (2026-2033) & (M USD)
Table 95. Asia Pacific Tagrisso (Osimertinib) Sales Forecast by Region (2026-2033) & (K MT)
Table 96. Asia Pacific Tagrisso (Osimertinib) Market Size Forecast by Region (2026-2033) & (M USD)
Table 97. South America Tagrisso (Osimertinib) Sales Forecast by Country (2026-2033) & (K MT)
Table 98. South America Tagrisso (Osimertinib) Market Size Forecast by Country (2026-2033) & (M USD)
Table 99. Middle East and Africa Tagrisso (Osimertinib) Sales Forecast by Country (2026-2033) & (Units)
Table 100. Middle East and Africa Tagrisso (Osimertinib) Market Size Forecast by Country (2026-2033) & (M USD)
Table 101. Global Tagrisso (Osimertinib) Sales Forecast by Type (2026-2033) & (K MT)
Table 102. Global Tagrisso (Osimertinib) Market Size Forecast by Type (2026-2033) & (M USD)
Table 103. Global Tagrisso (Osimertinib) Price Forecast by Type (2026-2033) & (USD/KG)
Table 104. Global Tagrisso (Osimertinib) Sales (K MT) Forecast by Application (2026-2033)
Table 105. Global Tagrisso (Osimertinib) Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Tagrisso (Osimertinib)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tagrisso (Osimertinib) Market Size (M USD), 2024-2033
Figure 5. Global Tagrisso (Osimertinib) Market Size (M USD) (2020-2033)
Figure 6. Global Tagrisso (Osimertinib) Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tagrisso (Osimertinib) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Tagrisso (Osimertinib) Product Life Cycle
Figure 13. Tagrisso (Osimertinib) Sales Share by Manufacturers in 2024
Figure 14. Global Tagrisso (Osimertinib) Revenue Share by Manufacturers in 2024
Figure 15. Tagrisso (Osimertinib) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Tagrisso (Osimertinib) Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Tagrisso (Osimertinib) Revenue in 2024
Figure 18. Industry Chain Map of Tagrisso (Osimertinib)
Figure 19. Global Tagrisso (Osimertinib) Market PEST Analysis
Figure 20. Global Tagrisso (Osimertinib) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Tagrisso (Osimertinib) Market Share by Type
Figure 27. Sales Market Share of Tagrisso (Osimertinib) by Type (2020-2025)
Figure 28. Sales Market Share of Tagrisso (Osimertinib) by Type in 2024
Figure 29. Market Size Share of Tagrisso (Osimertinib) by Type (2020-2025)
Figure 30. Market Size Share of Tagrisso (Osimertinib) by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Tagrisso (Osimertinib) Market Share by Application
Figure 33. Global Tagrisso (Osimertinib) Sales Market Share by Application (2020-2025)
Figure 34. Global Tagrisso (Osimertinib) Sales Market Share by Application in 2024
Figure 35. Global Tagrisso (Osimertinib) Market Share by Application (2020-2025)
Figure 36. Global Tagrisso (Osimertinib) Market Share by Application in 2024
Figure 37. Global Tagrisso (Osimertinib) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Tagrisso (Osimertinib) Sales Market Share by Region (2020-2025)
Figure 39. Global Tagrisso (Osimertinib) Market Size Market Share by Region (2020-2025)
Figure 40. North America Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Tagrisso (Osimertinib) Sales Market Share by Country in 2024
Figure 43. North America Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Tagrisso (Osimertinib) Market Size Market Share by Country in 2024
Figure 45. U.S. Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Tagrisso (Osimertinib) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Tagrisso (Osimertinib) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Tagrisso (Osimertinib) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Tagrisso (Osimertinib) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Tagrisso (Osimertinib) Sales Market Share by Country in 2024
Figure 53. Europe Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Tagrisso (Osimertinib) Market Size Market Share by Country in 2024
Figure 55. Germany Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Tagrisso (Osimertinib) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Tagrisso (Osimertinib) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Tagrisso (Osimertinib) Market Size Market Share by Region in 2024
Figure 68. China Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Tagrisso (Osimertinib) Sales and Growth Rate (K MT)
Figure 79. South America Tagrisso (Osimertinib) Sales Market Share by Country in 2024
Figure 80. South America Tagrisso (Osimertinib) Market Size and Growth Rate (M USD)
Figure 81. South America Tagrisso (Osimertinib) Market Size Market Share by Country in 2024
Figure 82. Brazil Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Tagrisso (Osimertinib) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Tagrisso (Osimertinib) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Tagrisso (Osimertinib) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Tagrisso (Osimertinib) Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Tagrisso (Osimertinib) Production Market Share by Region (2020-2025)
Figure 103. North America Tagrisso (Osimertinib) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Tagrisso (Osimertinib) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Tagrisso (Osimertinib) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Tagrisso (Osimertinib) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Tagrisso (Osimertinib) Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Tagrisso (Osimertinib) Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Tagrisso (Osimertinib) Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Tagrisso (Osimertinib) Market Share Forecast by Type (2026-2033)
Figure 111. Global Tagrisso (Osimertinib) Sales Forecast by Application (2026-2033)
Figure 112. Global Tagrisso (Osimertinib) Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Tagrisso (Osimertinib)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tagrisso (Osimertinib) Market Size (M USD), 2024-2033
Figure 5. Global Tagrisso (Osimertinib) Market Size (M USD) (2020-2033)
Figure 6. Global Tagrisso (Osimertinib) Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tagrisso (Osimertinib) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Tagrisso (Osimertinib) Product Life Cycle
Figure 13. Tagrisso (Osimertinib) Sales Share by Manufacturers in 2024
Figure 14. Global Tagrisso (Osimertinib) Revenue Share by Manufacturers in 2024
Figure 15. Tagrisso (Osimertinib) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Tagrisso (Osimertinib) Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Tagrisso (Osimertinib) Revenue in 2024
Figure 18. Industry Chain Map of Tagrisso (Osimertinib)
Figure 19. Global Tagrisso (Osimertinib) Market PEST Analysis
Figure 20. Global Tagrisso (Osimertinib) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Tagrisso (Osimertinib) Market Share by Type
Figure 27. Sales Market Share of Tagrisso (Osimertinib) by Type (2020-2025)
Figure 28. Sales Market Share of Tagrisso (Osimertinib) by Type in 2024
Figure 29. Market Size Share of Tagrisso (Osimertinib) by Type (2020-2025)
Figure 30. Market Size Share of Tagrisso (Osimertinib) by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Tagrisso (Osimertinib) Market Share by Application
Figure 33. Global Tagrisso (Osimertinib) Sales Market Share by Application (2020-2025)
Figure 34. Global Tagrisso (Osimertinib) Sales Market Share by Application in 2024
Figure 35. Global Tagrisso (Osimertinib) Market Share by Application (2020-2025)
Figure 36. Global Tagrisso (Osimertinib) Market Share by Application in 2024
Figure 37. Global Tagrisso (Osimertinib) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Tagrisso (Osimertinib) Sales Market Share by Region (2020-2025)
Figure 39. Global Tagrisso (Osimertinib) Market Size Market Share by Region (2020-2025)
Figure 40. North America Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Tagrisso (Osimertinib) Sales Market Share by Country in 2024
Figure 43. North America Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Tagrisso (Osimertinib) Market Size Market Share by Country in 2024
Figure 45. U.S. Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Tagrisso (Osimertinib) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Tagrisso (Osimertinib) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Tagrisso (Osimertinib) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Tagrisso (Osimertinib) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Tagrisso (Osimertinib) Sales Market Share by Country in 2024
Figure 53. Europe Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Tagrisso (Osimertinib) Market Size Market Share by Country in 2024
Figure 55. Germany Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Tagrisso (Osimertinib) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Tagrisso (Osimertinib) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Tagrisso (Osimertinib) Market Size Market Share by Region in 2024
Figure 68. China Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Tagrisso (Osimertinib) Sales and Growth Rate (K MT)
Figure 79. South America Tagrisso (Osimertinib) Sales Market Share by Country in 2024
Figure 80. South America Tagrisso (Osimertinib) Market Size and Growth Rate (M USD)
Figure 81. South America Tagrisso (Osimertinib) Market Size Market Share by Country in 2024
Figure 82. Brazil Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Tagrisso (Osimertinib) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Tagrisso (Osimertinib) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Tagrisso (Osimertinib) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Tagrisso (Osimertinib) Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Tagrisso (Osimertinib) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Tagrisso (Osimertinib) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Tagrisso (Osimertinib) Production Market Share by Region (2020-2025)
Figure 103. North America Tagrisso (Osimertinib) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Tagrisso (Osimertinib) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Tagrisso (Osimertinib) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Tagrisso (Osimertinib) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Tagrisso (Osimertinib) Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Tagrisso (Osimertinib) Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Tagrisso (Osimertinib) Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Tagrisso (Osimertinib) Market Share Forecast by Type (2026-2033)
Figure 111. Global Tagrisso (Osimertinib) Sales Forecast by Application (2026-2033)
Figure 112. Global Tagrisso (Osimertinib) Market Share Forecast by Application (2026-2033)
